mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
JQ-1 |
GDSC1000 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
AZD8055 |
GDSC1000 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
Crizotinib |
FIMM |
pan-cancer |
AAC |
0.096 |
0.6 |